Advertisement
Screener

AngioDynamics, Inc. (ANGO) Scorecard

2.8 / 5 stars · 68/120 Roast Me

26/120 1.1 / 5 stars All 120 Win/Lose results shown below

ANGO Roast Me summary

ANGIODYNAMICS INC (ANGO). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

  • 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 24 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q20/3 LoseANGO / S&P
14.42% / 15.20%
LoseANGO / S&P
9.46% / 15.00%
LoseANGO / S&P
ANGO unavailable / 50.40%
2026-Q10/3 LoseANGO / S&P
-11.45% / -4.33%
LoseANGO / S&P
10.73% / 11.30%
LoseANGO / S&P
ANGO unavailable / 27.70%
2025-Q41/3 WinANGO / S&P
14.95% / 2.65%
LoseANGO / S&P
7.26% / 9.00%
LoseANGO / S&P
ANGO unavailable / 13.40%
2025-Q31/3 WinANGO / S&P
12.60% / 8.12%
LoseANGO / S&P
2.73% / 4.61%
LoseANGO / S&P
ANGO unavailable / 13.45%
2025-Q20/3 LoseANGO / S&P
5.64% / 10.94%
LoseANGO / S&P
-3.76% / 4.83%
LoseANGO / S&P
ANGO unavailable / 10.63%
2025-Q11/3 WinANGO / S&P
2.51% / -4.27%
LoseANGO / S&P
-12.56% / 4.98%
LoseANGO / S&P
ANGO unavailable / 10.57%
2024-Q41/3 WinANGO / S&P
17.74% / 2.41%
LoseANGO / S&P
-13.06% / 5.25%
LoseANGO / S&P
ANGO unavailable / 6.15%
2024-Q31/3 WinANGO / S&P
28.60% / 5.89%
LoseANGO / S&P
-12.85% / 5.89%
LoseANGO / S&P
-3868.75% / 6.11%
2024-Q20/3 LoseANGO / S&P
3.07% / 4.28%
LoseANGO / S&P
-10.28% / 5.38%
LoseANGO / S&P
ANGO unavailable / 5.12%
2024-Q10/3 LoseANGO / S&P
-25.13% / 10.56%
LoseANGO / S&P
-3.19% / 5.71%
LoseANGO / S&P
ANGO unavailable / 5.59%
2023-Q40/3 LoseANGO / S&P
7.25% / 11.69%
LoseANGO / S&P
0.49% / 6.81%
LoseANGO / S&P
ANGO unavailable / 7.78%
2023-Q30/3 LoseANGO / S&P
-29.91% / -3.27%
LoseANGO / S&P
4.71% / 7.52%
LoseANGO / S&P
ANGO unavailable / -5.03%
2023-Q20/3 LoseANGO / S&P
0.87% / 8.74%
LoseANGO / S&P
7.13% / 9.50%
LoseANGO / S&P
ANGO unavailable / -8.57%
2023-Q10/3 LoseANGO / S&P
-24.91% / 7.50%
LoseANGO / S&P
9.35% / 10.77%
LoseANGO / S&P
ANGO unavailable / -15.69%
2022-Q40/3 LoseANGO / S&P
-32.70% / 7.56%
LoseANGO / S&P
8.13% / 11.88%
LoseANGO / S&P
ANGO unavailable / -17.99%
2022-Q31/3 WinANGO / S&P
5.74% / -4.88%
LoseANGO / S&P
7.73% / 13.47%
LoseANGO / S&P
ANGO unavailable / -1.41%
2022-Q21/3 WinANGO / S&P
-10.17% / -16.10%
LoseANGO / S&P
8.66% / 13.71%
LoseANGO / S&P
ANGO unavailable / 11.04%
2022-Q10/3 LoseANGO / S&P
-21.90% / -4.60%
LoseANGO / S&P
ANGO unavailable / 15.97%
LoseANGO / S&P
ANGO unavailable / 42.23%
2021-Q40/3 LoseANGO / S&P
6.32% / 11.03%
LoseANGO / S&P
ANGO unavailable / 15.00%
LoseANGO / S&P
ANGO unavailable / 96.40%
2021-Q30/3 LoseANGO / S&P
-4.39% / 0.58%
LoseANGO / S&P
ANGO unavailable / 10.77%
LoseANGO / S&P
ANGO unavailable / 69.42%
2021-Q22/3 WinANGO / S&P
15.94% / 8.55%
WinANGO / S&P
10.17% / 6.58%
LoseANGO / S&P
ANGO unavailable / 51.81%
2021-Q11/3 WinANGO / S&P
52.64% / 6.17%
LoseANGO / S&P
ANGO unavailable / -1.06%
LoseANGO / S&P
-436.36% / 7.39%
2020-Q41/3 WinANGO / S&P
27.11% / 12.15%
LoseANGO / S&P
ANGO unavailable / -3.72%
LoseANGO / S&P
-402.01% / -33.42%
2020-Q31/3 WinANGO / S&P
18.58% / 8.93%
LoseANGO / S&P
ANGO unavailable / -2.04%
LoseANGO / S&P
-375.31% / -27.10%
2020-Q20/3 LoseANGO / S&P
-2.49% / 20.54%
LoseANGO / S&P
ANGO unavailable / -0.46%
LoseANGO / S&P
-367.68% / -27.11%
2020-Q11/3 LoseANGO / S&P
-34.85% / -19.60%
LoseANGO / S&P
ANGO unavailable / 3.47%
WinANGO / S&P
915.38% / -14.75%
2019-Q41/3 LoseANGO / S&P
-13.08% / 9.07%
LoseANGO / S&P
ANGO unavailable / 5.36%
WinANGO / S&P
210.42% / 2.99%
2019-Q31/3 LoseANGO / S&P
-6.45% / 1.70%
LoseANGO / S&P
ANGO unavailable / 5.02%
WinANGO / S&P
276.74% / 0.21%
2019-Q21/3 LoseANGO / S&P
-13.87% / 4.30%
LoseANGO / S&P
ANGO unavailable / 6.64%
WinANGO / S&P
272.73% / 8.65%
2019-Q11/3 LoseANGO / S&P
13.56% / 13.65%
LoseANGO / S&P
ANGO unavailable / 8.12%
WinANGO / S&P
225.00% / 14.29%
2018-Q41/3 WinANGO / S&P
-7.41% / -13.52%
LoseANGO / S&P
ANGO unavailable / 9.05%
LoseANGO / S&P
ANGO unavailable / 18.23%
2018-Q31/3 LoseANGO / S&P
-2.25% / 7.71%
LoseANGO / S&P
ANGO unavailable / 10.21%
WinANGO / S&P
290.91% / 19.06%
2018-Q22/3 WinANGO / S&P
28.93% / 3.43%
LoseANGO / S&P
ANGO unavailable / 9.03%
WinANGO / S&P
214.29% / 14.46%
2018-Q11/3 WinANGO / S&P
3.73% / -0.76%
LoseANGO / S&P
-3.72% / 7.68%
LoseANGO / S&P
ANGO unavailable / 12.46%
2017-Q40/3 LoseANGO / S&P
-2.69% / 6.64%
LoseANGO / S&P
-3.73% / 7.03%
LoseANGO / S&P
ANGO unavailable / 13.82%
2017-Q31/3 WinANGO / S&P
5.43% / 4.48%
LoseANGO / S&P
-3.15% / 5.68%
LoseANGO / S&P
ANGO unavailable / 17.57%
2017-Q20/3 LoseANGO / S&P
-6.57% / 3.09%
LoseANGO / S&P
-1.20% / 4.83%
LoseANGO / S&P
ANGO unavailable / 17.74%
2017-Q10/3 LoseANGO / S&P
2.85% / 6.07%
LoseANGO / S&P
1.42% / 3.67%
LoseANGO / S&P
ANGO unavailable / 13.32%
2016-Q41/3 LoseANGO / S&P
-3.82% / 3.82%
WinANGO / S&P
2.18% / 2.09%
LoseANGO / S&P
ANGO unavailable / 7.05%
2016-Q32/3 WinANGO / S&P
22.06% / 3.85%
WinANGO / S&P
1.43% / 0.20%
LoseANGO / S&P
ANGO unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-28

MetricANGO total returnS&P 500 Total Return Index
Total return54.48%20.78%
Annualized return54.48%20.78%

5Y · 2021-09-01 to 2026-08-28

MetricANGO total returnS&P 500 Total Return Index
Total return-45.72%83.14%
Annualized return-11.50%12.86%

10Y · 2016-09-01 to 2026-08-28

MetricANGO total returnS&P 500 Total Return Index
Total return-4.40%319.30%
Annualized return-0.45%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-24.

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
SI-BONE, Inc. (SIBN)United States$0.830B-49.82